| |
| |
|
| Insider
Information: |
Primiano Christopher Brett |
| Relationship: |
Chief Business Officer |
| City: |
Natick |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
13,273 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$5,134 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
13,273 |
|
|
| Total
Value |
$5,134 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -10.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Karyopharm Therapeutics Inc. |
KPTI |
EVP, CBO, GC & Secretary |
2020-12-01 |
4,523 |
2014-05-13 |
0 |
Premium* |
|
|
Aura Biosciences, Inc. |
AURA |
Chief Business Officer |
2021-10-28 |
8,750 |
2021-10-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AURA |
Aura Biosciences, Inc. |
Chief Business Officer |
• – – |
2021-10-28 |
4 |
A |
$0.00 |
$0 |
D/D |
8,750 |
8,750 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
VP, GEN COUNSEL & SECRETARY |
• – – |
2014-05-13 |
4 |
B |
$26.75 |
$26,750 |
D/D |
1,000 |
1,000 |
2.74 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP,CORP DEV,GEN COUNSEL&SEC. |
• – – |
2016-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
20,161 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP,CORP DEV,GEN COUNSEL&SEC. |
• – – |
2016-11-09 |
4 |
S |
$8.19 |
$35,544 |
D/D |
(4,342) |
15,819 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, OPS, BUS DEV, GC & SEC |
• – – |
2017-06-26 |
4 |
AS |
$10.03 |
$8,071 |
D/D |
(805) |
14,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, OPS, BUS DEV, GC & SEC |
• – – |
2017-08-29 |
4 |
AS |
$10.00 |
$21,950 |
D/D |
(2,195) |
15,686 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, OPS, BUS DEV, GC & SEC |
• – – |
2017-09-15 |
4 |
AS |
$11.00 |
$22,000 |
D/D |
(2,000) |
12,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, OPS, BUS DEV, GC & SEC |
• – – |
2017-10-02 |
4 |
AS |
$12.00 |
$18,000 |
D/D |
(1,500) |
11,381 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, OPS, BUS DEV, GC & SEC |
• – – |
2017-11-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,000 |
26,381 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, OPS, BUS DEV, GC & SEC |
• – – |
2017-11-07 |
4 |
S |
$11.25 |
$55,755 |
D/D |
(4,958) |
21,423 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, OPS, BUS DEV, GC & SEC |
• – – |
2017-12-11 |
4 |
AS |
$10.88 |
$109,256 |
D/D |
(10,042) |
11,381 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, OPS, BUS DEV, GC & SEC |
• – – |
2017-12-12 |
4 |
AS |
$9.59 |
$168,616 |
D/D |
(17,000) |
11,381 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
SVP, OPS, BUS DEV, GC & SEC |
• – – |
2017-12-12 |
4 |
OE |
$6.54 |
$111,180 |
D/D |
17,000 |
28,381 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-02-07 |
4 |
AS |
$13.00 |
$19,500 |
D/D |
(1,500) |
9,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-02-15 |
4 |
AS |
$15.02 |
$15,229 |
D/D |
(1,014) |
8,867 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-02-16 |
4 |
AS |
$15.01 |
$22,298 |
D/D |
(1,486) |
7,381 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-03-05 |
4 |
AS |
$16.03 |
$40,076 |
D/D |
(2,500) |
4,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-05-10 |
4 |
AS |
$18.01 |
$36,024 |
D/D |
(2,000) |
2,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-09-10 |
4 |
AS |
$18.90 |
$189,046 |
D/D |
(10,000) |
2,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2018-09-10 |
4 |
OE |
$6.54 |
$84,650 |
D/D |
10,000 |
12,881 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2019-12-06 |
4 |
OE |
$6.54 |
$84,650 |
D/D |
10,000 |
16,653 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2019-12-06 |
4 |
AS |
$17.45 |
$226,908 |
D/D |
(13,000) |
3,653 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2019-12-27 |
4 |
AS |
$20.00 |
$100,000 |
D/D |
(5,000) |
3,653 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2019-12-27 |
4 |
OE |
$10.39 |
$51,950 |
D/D |
5,000 |
8,653 |
0 |
- |
|
| KPTI |
Karyopharm Therapeutics I... |
EVP, CBO, GC & Secretary |
• – – |
2020-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,675 |
13,328 |
0 |
- |
|
37 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
